Changeflow GovPing Pharma & Drug Safety Amorus Pharmaceutical Trademark Application
Routine Notice Added Final

Amorus Pharmaceutical Trademark Application

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The USPTO published trademark application TM79441630 for AMORUS covering pharmaceutical goods and medical apparatus including filled syringes, dermatological products, injectable dermal fillers, and related medical instruments. The mark was filed on November 27, 2025 and published on April 1, 2026, opening a standard 30-day opposition period for third parties.

What changed

The USPTO published the AMORUS pharmaceutical trademark application (TM79441630) on April 1, 2026. The application covers pharmaceutical goods (drugs, dermatological products, injectable dermal fillers, tissue-regenerative preparations) and medical apparatus (prefilled syringes, injection devices, orthopedic articles, LED skin improvement devices). Goods are classified under International Class 05 (pharmaceuticals) and Class 10 (medical instruments).

Third parties wishing to oppose registration of this mark have a standard 30-day window from the publication date. Competitors in the pharmaceutical, medical device, or dermatology sectors should review the goods covered and file an opposition if they have grounds under the Lanham Act. No specific compliance deadlines apply to the applicant at this stage beyond standard prosecution timelines.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

AMORUS

Published for Opposition TM79441630 Kind: published Apr 01, 2026

Abstract

Filled syringes for medical purposes [containing pharmaceuticals]; lactose for pharmaceutical purposes; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; drugs for medical purposes; adhesive skin patches for medical use; surgical implants comprised of living tissues; medicines for human purposes; tissue-regenerative pharmaceutical preparations; dermatological pharmaceutical products; injectable dermal fillers.; Multishot needle syringes; medical apparatus and instruments for skin improvement with LED light; esthetic massage apparatus; medical apparatus and instruments; medical instruments; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for injecting fillers; orthopedic articles; portable electric peeling machines for the cosmetic treatment of the face; injection device for pharmaceuticals.

Filing Date

2025-11-27

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
November 27th, 2025
Comment period closes
May 1st, 2026 (22 days)
Compliance deadline
May 1st, 2026 (22 days)
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79441630

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.